3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
olaparib
6
Specimen Handling
5
Paclitaxel
5
Magnetic Resonance Spectroscopy
5
Cyclophosphamide
4
Carboplatin
4
pembrolizumab
3
fludarabine
3
X-Rays
3
Taxes
3
Metformin
3
Letrozole
3
Fluorodeoxyglucose F18
3
Biopsy
3
Aspirin
3
niraparib
2
Tirzepatide
2
Radiotherapy
2
Propranolol
2
Platinum
2
Pafolacianine
2
Oncolytic Virotherapy
2
Hysterectomy
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fluorescein
2
Drug Therapy
2
Doxorubicin
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
sodium thiosulfate
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled